183 related articles for article (PubMed ID: 30180807)
1. Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing K
Zhang R; Zhou X; Shen X; Xie T; Xu C; Zou Z; Dong J; Liao L
Mol Med; 2018 Sep; 24(1):47. PubMed ID: 30180807
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effects of Three Sulfonylureas (Glibenclamide, Glimepiride, and Gliclazide) on Proliferation and Migration of Vascular Smooth Muscle Cells.
Zhang R; Zou Z; Zhou X; Shen X; Fan Z; Xie T; Xu C; Liao L; Dong J
Cell Physiol Biochem; 2019; 52(1):16-26. PubMed ID: 30790502
[TBL] [Abstract][Full Text] [Related]
3. Effects of sulfonylureas on K(ATP) channel-dependent vasodilation.
Cyrino FZ; Bottino DA; Coelho FC; Ravel D; Bouskela E
J Diabetes Complications; 2003; 17(2 Suppl):6-10. PubMed ID: 12623162
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers.
Ravel D; Levens N; Félétou M; Néliat G; Auclair J; Bouskela E
Fundam Clin Pharmacol; 2003 Feb; 17(1):61-9. PubMed ID: 12588631
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
7. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
Tawfik MK; Abo-Elmatty DM; Ahmed AA
Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
[TBL] [Abstract][Full Text] [Related]
8. Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
Bouskela E; Cyrino FZ; Conde CM; Garcia AA
Metabolism; 1997 Dec; 46(12 Suppl 1):26-30. PubMed ID: 9439555
[TBL] [Abstract][Full Text] [Related]
9. Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death.
Magnusson NE; Dyrskjøt L; Grimm D; Wehland M; Pietsch J; Rungby J
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):254-61. PubMed ID: 22642398
[TBL] [Abstract][Full Text] [Related]
10. Binding of sulphonylureas to plasma proteins - A KATP channel perspective.
Proks P; Kramer H; Haythorne E; Ashcroft FM
PLoS One; 2018; 13(5):e0197634. PubMed ID: 29772022
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of gliclazide on high glucose and AGEs-induced damage of glomerular mesangial cells and renal tubular epithelial cells via inhibiting RAGE-p22phox-NF-kB pathway.
Yang PY; Li PC; Feng B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9099-9107. PubMed ID: 31696501
[TBL] [Abstract][Full Text] [Related]
12. Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart.
Wu GT; Wang L; Li J; Zhu WZ
Chin Med Sci J; 2007 Sep; 22(3):162-8. PubMed ID: 17966164
[TBL] [Abstract][Full Text] [Related]
13. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.
Bijlstra PJ; Lutterman JA; Russel FG; Thien T; Smits P
Diabetologia; 1996 Sep; 39(9):1083-90. PubMed ID: 8877293
[TBL] [Abstract][Full Text] [Related]
14. Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injury.
Yilmaz TU; Yazihan N; Dalgic A; Kaya EE; Salman B; Kocak M; Akcil E
Indian J Med Res; 2015 Jun; 141(6):807-15. PubMed ID: 26205024
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Lang VY; Fatehi M; Light PE
Pharmacogenet Genomics; 2012 Mar; 22(3):206-14. PubMed ID: 22209866
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
17. A potential role of calpains in sulfonylureas (SUs) -mediated death of human pancreatic cancer cells (1.2B4).
Szymczak-Pajor I; Fleszar K; Kasznicki J; Gralewska P; Śliwińska A
Toxicol In Vitro; 2021 Jun; 73():105128. PubMed ID: 33652124
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
19. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
Chan TK; Chan V; Teng CS; Yeung RT
Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
[TBL] [Abstract][Full Text] [Related]
20. K
Singh B; Khattab F; Chae H; Desmet L; Herrera PL; Gilon P
Mol Metab; 2021 Nov; 53():101268. PubMed ID: 34118477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
